How can investors identify high-dividend Big Pharma stocks like those with 12% yields?

Investors can identify high-dividend Big Pharma stocks, such as those offering 12% yields, by focusing on key financial metrics and market factors. Start by screening for large-cap pharmaceutical companies with strong dividend histories, using tools like stock screeners to filter for dividend yields above the sector average (e.g., over 5-6%). Analyze the company's payout ratio—dividends as a percentage of earnings—to ensure sustainability; a ratio below 60-70% is generally safe. Look for companies with stable or growing revenues from blockbuster drugs, diverse product portfolios, and robust cash flows, as these support consistent dividends. Also, consider the stock's valuation: a high yield might result from a depressed stock price due to temporary issues like patent expirations or regulatory setbacks, which could present buying opportunities if the company's long-term prospects remain solid. Research the company's drug pipeline and R&D investments to gauge future growth potential. Monitor industry trends, such as demand for specialty drugs or generic competition. Consulting financial news sources like TheStreet Pro can provide insights and recommendations, but always cross-reference with SEC filings and analyst reports to make informed decisions tailored to your risk tolerance and investment goals.

📖 Read the full article: Clipping a 12% Coupon on a Big Pharma Name - TheStreet Pro